Related Experiment Video
Updated: Feb 12, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Dysfunction of antigen processing and presentation by dendritic cells in cancer
Joanna Bandola-Simon1, Paul A Roche1
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
Abstract:
The ability to mount an effective anti-tumor immune response requires coordinate control of CD4 T cell and CD8 T cell function by antigen presenting cells (APCs). Unfortunately, tumors create an immunosuppressive microenvironment that helps protect tumor cells from immune recognition. In many cases this defect can be traced back to a failure of APCs (most importantly dendritic cells (DCs)) to recognize, process, and present tumor antigens to T cells. In this review, we will summarize work addressing the role of different DC subsets in anti-tumor immunity and the various mechanisms used by tumor cells to suppress the ability of APCs to stimulate potent anti-tumor T cell responses.
Insights
Effective anti-tumor immunity needs antigen-presenting cells (APCs) to control T cell function. Tumors create immunosuppressive environments, often due to APCs failing to present tumor antigens, hindering T cell responses.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Effective anti-tumor immunity relies on antigen-presenting cells (APCs) to coordinate CD4 and CD8 T cell functions.
- Tumors establish immunosuppressive microenvironments that shield them from immune detection.
- A key defect involves APCs, particularly dendritic cells (DCs), failing to process and present tumor antigens to T cells.
Purpose of the Study:
- To review the critical roles of various dendritic cell (DC) subsets in anti-tumor immunity.
- To summarize the mechanisms tumors employ to suppress APC function.
- To highlight the importance of APCs in initiating anti-tumor T cell responses.
Main Methods:
- Literature review of studies on DC subsets and anti-tumor immunity.
- Analysis of tumor-induced immunosuppression mechanisms affecting APCs.
- Synthesis of research on APC-T cell interactions in the tumor microenvironment.
Main Results:
- Different DC subsets play distinct roles in initiating and regulating anti-tumor immune responses.
- Tumor cells utilize diverse strategies to inhibit DC maturation, antigen presentation, and T cell activation.
- Impaired APC function is a common hallmark of tumor-induced immune evasion.
Conclusions:
- Restoring or enhancing APC function is crucial for overcoming tumor-induced immunosuppression.
- Targeting tumor evasion mechanisms that suppress APCs holds therapeutic potential for cancer immunotherapy.
- Understanding DC subset-specific functions is key to developing effective anti-tumor strategies.
Related Concept Videos
Processes of Self-Presentation
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Self-Presentation: Self-Monitoring and Self-Handicapping
Self-Presentation
Strategies of Self-Presentation I: Strategic Self-Presentation
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...

